Search results
Check Out What Whales Are Doing With MRK - Merck & Co (NYSE:MRK)
Benzinga· 17 hours agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK . And retail traders should know. We noticed ...
MRK- A Big Pharma Name Growing Via Acquisitions, Product Launches
MoneyShow via Yahoo Finance· 2 days agoMerck & Co. (MRK) is a leading global drugmaker, producing a wide range of prescription drugs and vaccines in many therapeutic areas ...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 1 day agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Off the news: New dengue vaccine eyed as cases grow | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 3 days agoWith a state of emergency in Puerto Rico, where mosquito-spread dengue fever is endemic, and two cases of travel-related dengue fever reported in Hawaii last month, a push is growing for U.S ...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks· 3 days agoMerck (MRK) discontinues the Keytruda plus vibostolimab co-formulation arm of a phase III study due to a higher rate of patient discontinuation.
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
Reuters· 3 days ago, opens new tab said on Tuesday the U.S. Food and Drug Administration (FDA) has declined to approve...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 21 hours agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Merck Expands Access to High-Quality Maternal Care for More
3BL CSRwire· 4 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global maternal health initiative, has reached more than 30 million ...
Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination...
Benzinga· 3 days agoOSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that
Tri-Cities doctor fined after prescribing ivermectin for COVID. 2nd physician charged
Tri-City Herald via Yahoo News· 6 days agoOne doctor joined in a lawsuit against the Washington Medical Commission with the help of the Silent...